CinCor Pharma, Inc. Additional Paid in Capital
CinCor Pharma, Inc. had Additional Paid in Capital of $656.27 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2022-11-03
- 2022-09-30: Additional Paid in Capital $656.27M.
- 2022-06-30: Additional Paid in Capital $411.92M.
- 2022-03-31: Additional Paid in Capital $410.68M.
- 2021-12-31: Additional Paid in Capital $13.99M.
| Period end | Additional Paid in Capital |
|---|---|
| 2022-09-30 | $656.27M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $411.92M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $410.68M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $13.99M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $69.33K 10-K · filed 2022-03-22 |